How Lucrative is Global Home Potassium Monitoring Devices Market

The purpose of the strategic research study titled "Home Potassium Monitoring Devices Market - Global Industry Perspective Comprehensive Analysis and Forecast 2020 - 2028" is to offer industry investors, company executives, and industry participants with in-depth analysis to enable them make informed strategic decisions related to the opportunities in the industry.

USP & Key Offerings
Home Potassium Monitoring Devices Market Size in terms of Revenue (USD Million) from 2023 to 2031
Historical & Descriptive Analysis from 2023 to 2031
Forecasts & Predictive Analysis from 2023 to 2031
Market Drivers, Restraints, Opportunities, & Regional Market Trends
Home Potassium Monitoring Devices Market Attractiveness Analysis
Segment Analysis by Region and Country
Competitive Landscape and Company Market Share Analysis
COVID-19 Impact Analysis

For full report overview visit @ https://flairintelligence.com/global-home-potassium-monitoring-devices-market-analysis-and-opportunities-2023-2031/

About 20 million Americans suffer from chronic kidney disease (CKD), and of these, over half a million have impaired kidney function and require frequent dialysis treatment. Dialysis patients are at high risk of hyperkalemia, a condition where serum potassium levels are elevated above 3.5-5.5 mmol/L . Hyperkalemia is known to be a silent killer, as symptoms often do not present themselves until potassium levels are severely elevated, resulting in heart palpitations, muscle pain and weakness, and potentially cardiac arrhythmia and death . The risk that hyperkalemia poses to dialysis patients is evident when based on mortality trends for each day of the week. The current standard of care consists of three dialysis treatments per week, Monday-Wednesday-Friday (MWF) or Tuesday Thursday-Saturday (TTS) cycle. On the two-day intervals (either Sat/Sun or Sun/Mon depending on the schedule) during which patients receive no treatment, the instance of sudden cardiac death increases three-fold, as patients are unable to remove toxic substances from their blood themselves. This problem is further exacerbated by the fact that 24% of dialysis patients miss their scheduled treatments, prolonging the time spent between treatments and increasing the risk for cardiac complications. The increased mortality rate of patients due to cardiac complications strongly suggests that hyperkalemia is a potential major cause of death. According to the United States Renal Data System Annual Report (2017), over 42% of deaths of dialysis patients are cardiovascular in origin, amounting to nearly 40,000 deaths per year . This is markedly greater than the 25% of deaths that are cardiovascular in origin for the general population.

Office A & B, Kakade Terrace
Warje, Pune 411058
Mail: info@flairintelligence.com

Flair Intelligence is market research and consulting firm, with a vast expertise in technology and consumer goods reports. Our colossal repository of research reports, would present you with an in depth details about the market ranging from evolving trends, competitive analysis and bench marking, lucrative investment pockets, which will help your business drive profitable growth.
Our Major Services:
• Custom Research
• Industry Monitoring Services
• Syndicate Research

This release was published on openPR.